Skip to main content

Table 2 Baseline Pulmonary Function of IPF Patients According to FcγRIIa Genotypes

From: Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression

 

FcγRIIa Genotype

 
 

RR

RH

HH

Pvalue

Patients, n

53

61

28

 

Age, y

70.1 ± 8.9

70.1 ± 8.9

69.8 ± 10.5

NS

FEV 1 , L

2.31 ± 0.6

2.12 ± 0.6

1.96 ± 0.5

0.037

% predicted

93.0 ± 22.0

85.7 ± 17.4

81.5 ± 19.4

0.031

FVC, L

2.92 ± 0.8

2.75 ± 0.8

2.43 ± 0.6

0.026

% predicted

91.9 ± 20.6

87.1 ± 17.4

80.1 ± 20.7

0.041

FEV 1 /VC, % predicted

79.7 ± 9.4

77.5 ± 10.2

81.3 ± 9.7

NS

TLC, L

4.47 ± 0.9

4.82 ± 1.1

3.94 ± 1.0

NS

% predicted

76.7 ± 14.0

72.9 ± 15.8

71.8 ± 16.5

NS

D L CO , ml/min/mmHg

4.49 ± 1.4

3.98 ± 1.2

3.54 ± 1.4

0.012

% predicted

57.4 ± 15.4

51.4 ± 15.0

45.7 ± 16.4

0.007

K CO , ml/min/mmHg/L

1.17 ± 0.3

1.07 ± 0.3

1.06 ± 0.3

NS

% predicted

87.6 ± 24.6

80.1 ± 20.5

76.6 ± 22.9

NS

  1. Values as mean ± SD. P values (P) for RR vs. HH comparison. Abbreviations: NS: non-significant; IPF: idiopathic pulmonary fibrosis; DL CO: Diffusing capacity of the lung for carbon monoxide; KCO: DL COcorrected for lung volume.